Advertisement
Advertisement
BNGO
Bionano Genomics, Inc. Common Stock
1.24
USDSponsored
+0.07
+5.98%
May 20, 16:00 UTC -4
Closed
After-Market
1.23
-0.01
-1.21%
BNGO Earnings Reports
Positive Surprise Ratio
BNGO beat 12 of 31 last estimates.
39%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$7.67M
/-$0.90
Implied change from Q1 26 (Revenue/ EPS)
+14.71%
/+18.42%
Implied change from Q2 25 (Revenue/ EPS)
+13.92%
/-54.77%
Bionano Genomics, Inc. Common Stock earnings per share and revenue
On May 13, 2026, BNGO reported earnings of -0.76 USD per share (EPS) for Q1 26, beating the estimate of -0.96 USD, resulting in a 21.57% surprise. Revenue reached 6.69 million, compared to an expected 6.70 million, with a -0.18% difference. The market reacted with a -4.80% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.90 USD, with revenue projected to reach 7.67 million USD, implying an increase of 18.42% EPS, and increase of 14.71% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Annovis Bio, Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.40
Actual
-$0.63
Surprise
-56.37%
Rein Therapeutics, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.49
Actual
-$0.19
Surprise
+61.98%
CervoMed Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.79
Actual
-$0.86
Surprise
-8.09%
Neuphoria Therapeutics Inc. Common Stock
Report Date
May 15, 2026 For Q3 26
Estimate
-$0.98
Actual
-$0.09
Surprise
+90.90%
Lantern Pharma Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+18.30%
Allarity Therapeutics, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
EVOGENE LTD.
Report Date
May 20, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.60
Surprise
-117.86%
Immunovant, Inc. Common Stock
Report Date
May 20, 2026 For Q4 26
Estimate
-$0.61
Actual
-$0.73
Surprise
-19.11%
Compugen Ltd
Report Date
May 18, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.08
Surprise
-8.11%
Scilex Holding Company Common Stock
Report Date
May 20, 2026 For Q1 26
Estimate
-Actual
-$4.76
Surprise
-
FAQ
What were Bionano Genomics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Bionano Genomics, Inc. Common Stock reported EPS of -$0.76, beating estimates by 21.57%, and revenue of $6.69M, -0.18% below expectations.
How did the market react to Bionano Genomics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -4.8%, changed from $1.25 before the earnings release to $1.19 the day after.
When is Bionano Genomics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Bionano Genomics, Inc. Common Stock's next earnings report?
Based on 5
analysts, Bionano Genomics, Inc. Common Stock is expected to report EPS of -$0.90 and revenue of $7.67M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement